NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
- 专利权人:
- Mersana Therapeutics; Inc.
- 发明人:
- Eric P. HAILMAN,Donna M. JARLENSKI,Donald A. BERGSTROM
- 申请号：
- US16542642
- 公开号：
- US20200055933A1
- 申请日:
- 2019.08.16
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Dosing Regimen of Avelumab for the Treatment of Cancer
- Avelumab dosing regimen for the treatment of cancer
- SCHEMA POSOLOGIQUE D'AVELUMAB POUR LE TRAITEMENT DU CANCER
- Methods of Treating Cancer Using B-RAF Inhibitors and Immune Checkpoint Inhibitors
- METHOD OF TREATMENT USING CHECKPOINT KINASE 1 INHIBITORS
